Disclosure Panels Details Page
Hepatobiliary Cancers Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Thomas Abrams MD | None | Eisai Inc. Exelixis Inc. |
None | None | 03/08/2023 |
| Aijaz Ahmed MD | Intercept | Gilead Sciences, Inc. | Not Applicable | Not Applicable | 10/24/2022 |
| Daniel Anaya MD | DNAtrix | Roche Laboratories, Inc. | None | None | 09/17/2022 |
| Robert Anders PhD,MD | Bristol-Myers Squibb Company Rapt Therapeutics Standup 2 Cancer |
Bristol-Myers Squibb Company Merck & Co., Inc. |
None | None | 11/17/2022 |
| Chandrakanth Are MBA,FACS,FRCS,MBBS | None | Basavatarakam Indo-American Cancer Hospital and Research Institute- started in February 2020 | None | None | 01/14/2023 |
| Melinda Bachini | None | None | AstraZeneca Pharmaceuticals LP Boehringer Ingelheim GmbH Incyte Corporation Kinnate National Cancer Institute Relay Therapeutics Taiho Pharmaceuticals Co., Ltd. Tri-Salus |
None | 03/05/2023 |
| Al Benson III MD,FASCO,FACP | AIM Immuno Tech Astellas Pharma US, Inc. Boehringer Ingelheim GmbH Bristol-Myers Squibb Company GSK Mirati Mirati Therapeutics, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. PrECOG, LLC Tempus Terumo Therabionic |
Therabionic Artemida Bristol-Myers Squibb Company Janssen Oncology Natera Pfizer Inc./Hospira Inc. |
None | None | 05/09/2023 |
| David Binder MD | None | None | None | None | 09/02/2022 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Christopher Bowlus MD | Boston Scientific Corporation Bristol-Myers Squibb Company Calliditas Chemomab COUR Cymabay Gilead Sciences, Inc. GlaxoSmithKline Hanmi Intercept Ipsen Mirum Novartis Pharmaceuticals Corporation Novo Nordisk Pliant Viking |
Ipsen | None | None | 04/16/2023 |
| Daniel Brown MD,FSIR | None | None | Bard Bright Research Partners |
None | 05/05/2023 |
| Adam Burgoyne PhD,MD | AstraZeneca Pharmaceuticals LP Boston Scientific Corporation Cogent Biosciences Deciphera Pharmaceuticals, Inc. Exelixis Inc. Genentech, Inc. Jiangsu Hengrui Medicine Merck & Co., Inc. Teclison Tvardi Therapeutics |
Deciphera Pharmaceuticals, Inc. Exelixis Inc. |
AstraZeneca Pharmaceuticals LP Deciphera Pharmaceuticals, Inc. |
None | 10/10/2022 |
| Jason Castellanos MS,MD | None | None | None | None | 03/18/2023 |
| Prabhleen Chahal MD | Boston Scientific Corporation Medtronic, Inc. |
None | None | None | 03/06/2023 |
| Jordan Cloyd MD | None | None | None | None | 03/11/2023 |
| Anne Covey MD | None | None | None | Amgen Inc. | 07/20/2022 |
| Michael D'Angelica MD | None | None | None | None | 02/16/2023 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 05/24/2023 |
| Evan Glazer MD,PhD,FACS | Delcath | Anviron | None | None | 02/20/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| William Hawkins MD | Celldex Therapeutics | None | None | None | 01/05/2023 |
| Brianna Herron PharmD,BCPS,BCOP | None | None | None | None | 05/17/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Cindy Hochstetler PhD | None | None | None | None | 03/03/2023 |
| Renuka Iyer MD | AVEO Pharmaceuticals, Inc. Ipsen Lexicon Pharmaceuticals, Inc. Merck & Co., Inc. MimiVax, LLC |
AstraZeneca Pharmaceuticals LP Ipsen Puma Biotechnology Tersera |
None | None | 09/07/2022 |
| Rojymon Jacob MD | None | None | None | None | 03/01/2023 |
| Lawrence Jennings PhD,MD | None | None | None | None | 04/08/2023 |
| Robin Kelley MD | Agios, Inc. AstraZeneca Pharmaceuticals LP Bayer HealthCare Bristol-Myers Squibb Company Eli Lilly and Company EMD Serono Exelixis Inc. Genentech, Inc. LOXO Merck & Co., Inc. Novartis Pharmaceuticals Corporation Partner Therapeutics QED Relay Therapeutics Surface Oncology Taiho Pharmaceuticals Co., Ltd. |
Agios, Inc. AstraZeneca Pharmaceuticals LP Exact Sciences Exelixis Inc. Genentech, Inc. Ipsen Kinnate Merck & Co., Inc. Relay Therapeutics Servier |
None | None | 03/17/2023 |
| Robin Kim MD | None | None | None | None | 08/08/2022 |
| Matthew Levine PhD,MD | No commercial interest - institutionally funded clinical trial | Expert witness - medical legal | None | None | 06/18/2022 |
| Manisha Palta MD | Merck & Co., Inc. Varian Medical Systems, Inc. |
Syntactx UptoDate |
None | None | 05/22/2023 |
| James Park MD | None | None | None | None | 01/21/2023 |
| Sharon Park PharmD,BCOP | None | None | None | None | 05/09/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Steven Raman MD | Johnson & Johnson | Otsuka America Pharmaceutical, Inc. Profound |
Bayer HealthCare | Angiodynamics | 10/11/2022 |
| Sean Ronnekleiv-Kelly MD | None | None | None | None | 02/28/2023 |
| Vaibhav Sahai MS,MBBS | Actuate Therapeutics Agios, Inc. Bristol-Myers Squibb Company Celgene Corporation Clovis Oncology Cornerstone Exelixis Inc. Fibrogen Incyte Corporation Ipsen MedImmune Inc. National Cancer Institute Relay Therapeutics Repare Therapeutics Syros Pharmaceuticals |
AstraZeneca Pharmaceuticals LP Cornerstone Pharmaceuticals Delcath Systems GlaxoSmithKline Helsinn Therapeutics Histosonics Incyte Corporation Ipsen Kinnate Lynx Group Servier Pharmaceuticals Taiho Pharmaceuticals Co., Ltd. |
None | Cornerstone Pharmaceuticals | 01/09/2023 |
| Ryan Schonfeld BA | None | None | None | None | 05/05/2023 |
| Gagandeep Singh MD | None | None | None | None | 05/19/2023 |
| Stacey Stein MD | None | AstraZeneca Pharmaceuticals LP Eisai Inc. Exelixis Inc. Genentech, Inc. Imvax Ipsen Merck & Co., Inc. QED |
None | None | 09/13/2022 |
| Bettyanne Sunderland OCN,RN,BSN | None | None | None | None | 01/27/2023 |
| Samantha Tamburro CPON,RN,BSN | None | None | Flatiron Health, Inc. | None | 05/19/2023 |
| Anita Turk MD | Eli Lilly and Company | None | None | None | 04/06/2023 |
| Jean-Nicolas Vauthey MD | None | None | None | None | 02/13/2023 |
| Alan Venook MD | Amgen Inc. | Amgen Inc. Bayer HealthCare Bristol-Myers Squibb Company Exact Sciences Exelixis Inc. GlaxoSmithKline Merck & Co., Inc. Pfizer Inc. |
None | None | 03/06/2023 |
| Adam Yopp MD | None | None | None | None | 07/28/2022 |